Solarea Bio
Latest round
- Series B
Last raised
- May 2023
Total raised
- $26M
Investors
- 7
About Solarea Bio
Based in the US, Solarea Bio, Inc.Solarea Bio, Inc. specializes in creating innovative health solutions.23 mn.Solarea Bio specializes in developing all-natural solutions aimed at addressing age-related inflammatory conditions through their proprietary Microscape Technology™. This technology isolates beneficial bacteria and fungi found in fruits and vegetables, which are integrated into their product line. Their offerings include formulations designed to support individuals with rheumatoid arthritis, psoriatic arthritis, and cellular aging, specifically targeting clinically validated benefits such as slowing bone loss, with studies pending peer review and publication.Solarea Bio generates revenue through direct-to-consumer sales complemented by partnerships with healthcare providers and retailers in the health and wellness sector. The company allows customers to purchase its flagship products that leverage Microscape Technology™ for specific health concerns.In May 2023, Solarea Bio, Inc. The company aims to expand into various markets, further enhancing its reach within North America and select international regions.
Who invested in Solarea Bio
7 investors across 3 rounds
See all investors in Solarea Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Solarea Bio
Who invested in Solarea Bio?
Solarea Bio has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Solarea Bio raised?
Solarea Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Solarea Bio last raise money?
Solarea Bio's most recent round on record is a Series B, in May 2023.
What does Solarea Bio do?
Based in the US, Solarea Bio, Inc.
Where is Solarea Bio headquartered?
Solarea Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Solarea Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Solarea Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Solarea Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.